Position in TWST
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$161,624
+$142,594 QoQ
Shares Held
1,571
+24.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#257
of 334 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $10,816,250 across 18 Diagnostics & Research names. TWST ranks #3 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
24,410 | $6,626,089 | |
| 2 | A |
Agilent Technologies, Inc.
|
27,961 | $3,714,053 | |
| 3 | TWST |
Twist Bioscience Corp
This page
|
1,571 | $161,624 | |
| 4 | ILMN |
Illumina, Inc.
|
404 | $71,035 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
234 | $45,212 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
77 | $38,604 | |
| 7 | SHC |
Sotera Health Co
|
2,064 | $36,636 | |
| 8 | DHR |
Danaher Corp /De/
|
126 | $24,000 |
All Filings in TWST
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $161,624 | 1,571 | Shares | Sole | 2026-08-07 | |
| 2023-03-31 | $19,030 | 1,262 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,568,838 | 65,890 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,681 | 218 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,293 | 37 | Shares | Defined | 2022-08-08 | |
| 2021-09-30 | $352,355 | 3,294 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $443,855 | 3,331 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $281,406 | 2,272 | Shares | Defined | 2021-04-28 | |
| 2020-09-30 | $85,918 | 1,131 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $8,923 | 197 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $42,717 | 1,397 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||